| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Laxatives |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
|
ATC code A05 Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A05 is part of the anatomical group A Alimentary tract and metabolism.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QA05...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
Contents |
A05A Bile therapy
A05AA Bile acid preparations
- A05AA01 Chenodeoxycholic acid
- A05AA02 Ursodeoxycholic acid
A05AB Preparations for biliary tract therapy
- A05AB01 Nicotinyl methylamide
A05AX Other drugs for bile therapy
- A05AX01 Piprozolin
- A05AX02 Hymecromone
- A05AX03 Cyclobutyrol
- QA05AX90 Menbutone
A05B Liver therapy, lipotropics
A05BA Liver therapy
- A05BA01 Arginine glutamate
- A05BA03 Silymarin
- A05BA04 Citiolone
- A05BA05 Epomediol
- A05BA06 Ornithine oxoglutarate
- A05BA07 Tidiacic arginine
- A05BA08 Glycyrrhizic acid (glycyrrhizin)
- QA05BA90 Methionine
A05C Drugs for bile therapy and lipotropics in combination
References
|
||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
